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Abstract
Toxoplasma gondii resides in an intracellular compartment (parasitophorous vacuole) that excludes transmembrane
molecules required for endosome - lysosome recruitment. Thus, the parasite survives by avoiding lysosomal degradation.
However, autophagy can re-route the parasitophorous vacuole to the lysosomes and cause parasite killing. This raises the
possibility that T. gondii may deploy a strategy to prevent autophagic targeting to maintain the non-fusogenic nature of the
vacuole. We report that T. gondii activated EGFR in endothelial cells, retinal pigment epithelial cells and microglia. Blockade
of EGFR or its downstream molecule, Akt, caused targeting of the parasite by LC3+ structures, vacuole-lysosomal fusion,
lysosomal degradation and killing of the parasite that were dependent on the autophagy proteins Atg7 and Beclin 1.
Disassembly of GPCR or inhibition of metalloproteinases did not prevent EGFR-Akt activation. T. gondii micronemal proteins
(MICs) containing EGF domains (EGF-MICs; MIC3 and MIC6) appeared to promote EGFR activation. Parasites defective in
EGF-MICs (MIC1 ko, deficient in MIC1 and secretion of MIC6; MIC3 ko, deficient in MIC3; and MIC1-3 ko, deficient in MIC1,
MIC3 and secretion of MIC6) caused impaired EGFR-Akt activation and recombinant EGF-MICs (MIC3 and MIC6) caused
EGFR-Akt activation. In cells treated with autophagy stimulators (CD154, rapamycin) EGFR signaling inhibited LC3
accumulation around the parasite. Moreover, increased LC3 accumulation and parasite killing were noted in CD154-
activated cells infected with MIC1-3 ko parasites. Finally, recombinant MIC3 and MIC6 inhibited parasite killing triggered by
CD154 particularly against MIC1-3 ko parasites. Thus, our findings identified EGFR activation as a strategy used by T. gondii
to maintain the non-fusogenic nature of the parasitophorous vacuole and suggest that EGF-MICs have a novel role in
affecting signaling in host cells to promote parasite survival.
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Introduction
Toxoplasma gondii is an obligate intracellular protozoan parasite
that infects around a third of the human population worldwide. T.
gondii is of clinical importance because it causes encephalitis in
immunocompromised individuals and retino-choroiditis in immu-
nocompetent and immunosuppressed patients. T. gondii can also
cause congenital infection that may result in cerebral and ocular
disease. Tachyzoites of T. gondii infect virtually any nucleated cell
through active invasion. This process is dependent on the parasite
actin-myosin motor and sequential secretion of proteins from
micronemes and rhoptries, specialized organelles present in the
apical end of the parasite [1]. Once secreted, T. gondii micronemal
proteins (MICs) are expressed at the parasite surface membrane
and they interact with host cell receptors [2]. MICs contain
adhesive domains such as type I thrombospondin repeats, apple
domains, EGF repeats and integrin A domains [3,4]. The
connection between transmembrane MICs to the actin-myosin
motor (glideosome) of the parasite together with the binding of
host cell receptors by MICs is considered to enable the organism to
penetrate host cells [5,6]. Following the release of MICs, rhoptries
secrete rhoptry neck proteins (RONs) that are critical for the
formation of a structure called the moving junction (MJ) [7,8]. The
MJ anchors the parasite to the host cell while the parasite
penetrates it. The MJ is also believed to function as a sieve that
excludes host type I transmembrane proteins from entering the PV
membrane (PVM) [8,9]. The end result is the formation of a
parasitophorous vacuole that is devoid of host proteins required
for recruitment of endosomes and lysosomes [10].
T. gondii cannot withstand the lysosomal environment. Thus, the
non-fusogenic nature of the PV is critical since it allows the
parasite to survive and replicate. The immune system can deprive
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the parasite from this niche by disrupting the PVM through the
effects of IFN-c/Immunity related GTPases (IRG) [11,12] and by
making the PV fusogenic through the effects of CD40 ligation [13–
15]. CD40 re-routes the PV to the lysosomes through the
autophagy machinery [13–15].
Autophagy is a conserved cellular mechanism of lysosomal
degradation. During autophagy, portions of the cytosol or
organelles are encircled by an isolation membrane [16]. The
expansion of the isolation membrane results in the formation of a
double membrane structure called autophagosome that delivers its
contents to the lysosomes for degradation [16]. Autophagy is
recognized as a mechanism stimulated by innate and adaptive
immune mechanisms to degrade numerous intracellular pathogens
[17]. However, various bacteria and viruses have evolved
mechanisms to prevent autophagic degradation by targeting
autophagy proteins to avoid recognition by the autophagy
machinery or prevent the initiation and maturation of autophago-
somes [18–24]. Much less is known regarding whether pathogens
manipulate signaling cascades that regulate autophagy to prevent
their degradation. HIV-1 envelope can activate the negative
regulator of autophagy mTOR and it has been proposed that this
would prevent lysosomal degradation of virions [25]. Bioinfor-
matic analysis of human THP-1 cells infected with Mycobacterium
tuberculosis suggested that the pathogen activates host signaling
cascades that impair autophagy [26].
The highly successful nature of T. gondii as a pathogen together
with evidence that the autophagy pathway can trigger lysosomal
killing of the pathogen raise the possibility that T. gondii prevents
autophagic targeting of the PV to maintain the non-fusogenic
nature of the PV. Moreover, approximately 25–35% of various
CD40+ cells subjected to CD40 ligation are unable to kill T. gondii
further suggesting that the parasite may utilize mechanism(s) to
prevent induction of autophagic killing. Here we report that
maintenance of the non-fusogenic nature of the PV requires T.
gondii-induced activation of EGFR-Akt, a signaling cascade that
prevents autophagy protein-dependent vacuole-lysosomal fusion,
lysosomal degradation and killing of the parasite. Blockade of
EGFR-Akt may prove of therapeutic benefit for toxoplasmosis
since it is sufficient to induce killing of the parasite without the
need for immune-induced activation of host cells.
Results
T. gondii induces rapid Akt activation in non-
hematopoietic cells through phosphatidylinositol 3-
kinase (PI3K)
We determined whether Akt is quickly activated by T. gondii
during infection of various non-hematopoietic cells. Activation of
Akt is a multistep process where phosphorylation of Serine 473
results in full activation of the molecule [27]. Primary human
brain microvascular endothelial cells (HBMEC) were infected with
either type I (RH) or type II (ME49) strains of T. gondii under
conditions that caused synchronized infection. T. gondii infection
resulted in an enhanced phosphorylation of Akt Serine 473 as
assessed by immunoblot (Figure 1A). Similar results were obtained
with a mouse endothelial cell line mHEVc (Figure 1B). T. gondii
also caused Akt phosphorylation in a human retinal pigment
epithelial (RPE) cell line, an effect that decreased at later time
points post-infection (Figure 1C). We assessed whether viable
parasites are required to induce activation of Akt. HBMEC were
challenged with live or killed parasites followed by determination
of Akt activation. Viable but not killed tachyzoites induced Akt
phosphorylation (Figure 1D). Activation of phosphatidylinositol 3-
kinase (PI3K) with resulting production of phosphatidylinositol
3,4,5 trisphosphate (PIP3) production is a major trigger of Akt
activation [28]. The amino-terminal pleckstrin homology (PH)
domain of Akt mediates recruitment of this molecule to plasma
membrane containing increased PI(3,4,5)P3 or PI(3,4)P2 [29].
Indeed, the PH domain of Akt fused to GFP (PH-Akt-GFP) has
been used as a probe to examine sites of PIP3 accumulation [30].
HBMEC were transiently transfected with a plasmid encoding
PH-Akt-GFP followed by challenge with RH T. gondii that express
cytoplasmic RFP (T. gondii-RFP). T. gondii-infected cells exhibited
accumulation of PH-Akt-GFP around the parasite (Figure 1E). To
examine the role of PI3K in this process, HBMEC were incubated
with or without LY294002, a specific PI3K inhibitor, followed by
challenge with the parasite. LY294002 did not affect the
percentage of infected cells (not shown). Accumulation of PH-
Akt-GFP around T. gondii was ablated by LY294002 (p,0.01)
(Figure 1E). Moreover, incubation with LY294002 impaired the
upregulation of Akt phosphorylation induced by T. gondii,
especially in the earlier time points post-infection (Figure 1F).
Similarly, Akt phosphorylation during T. gondii infection was
impaired in HBMEC transfected with siRNA against the PI3K
catalytic subunit p110a (Figure 1G). Taken together, these
findings indicate that T. gondii induces rapid Akt activation in
non-hematopoietic cells in a manner that is dependent on PI3K.
Blockade of Akt induces accumulation of the autophagy
protein LC3 around the parasite, vacuole-lysosome
fusion and killing of T. gondii dependent on autophagy
proteins
We performed studies to investigate whether blockade of Akt
signaling promotes killing of T. gondii. HBMEC were incubated
with or without Akt inhibitor IV followed by challenge with T.
gondii. The percentage of infected cells at 2 hours and 24 hours
post-challenge were determined. Akt inhibitor IV did not impair
the percentage of infected cells at 2 h (Figure 2A). However,
treatment with Akt inhibitor IV markedly reduced the percentage
Author Summary
Toxoplasma gondii resides in a parasitophorous vacuole
that excludes transmembrane proteins required for
recruitment of endosomes and lysosomes and thus, does
not follow the path of classical lysosomal degradation.
However, the non-fusogenic nature of the vacuole can be
reverted when autophagy, a pathway to lysosomal
degradation, is upregulated through the immune system
or pharmacologically. Maintenance of the non-fusogenic
nature of the vacuole is central to parasite survival. Thus, in
addition to preventing degradation through a classical
lysosomal pathway, T. gondii may also deploy strategies to
prevent constitutive levels of autophagy from targeting
the pathogen and causing its lysosomal degradation. We
report that T. gondii accomplishes this task by causing
EGFR activation in host cells. In cells that were not
subjected to immune or pharmacologic upregulation of
autophagy, blockade of EGFR resulted in parasite encasing
by structures that expressed the autophagy protein LC3,
vacuole-lysosomal fusion and autophagy protein-depen-
dent killing of the parasite. Moreover, EGFR signaling also
impaired targeting of the parasite by LC3+ structures in
cells treated with stimulators of autophagy. Studies with T.
gondii deficient in EGF domain containing-micronemal
proteins (EGF-MICs) and recombinant EGF-MICs support
the concept that these parasite adhesins contribute to
EGFR activation.
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of infected cells at 24 h (p,0.01) (Figure 2A). Changes in the
percentage of infected cells were not due to preferential cell loss in
Akt inhibitor IV-treated cells since cell densities as determined
with an eyepiece grid were similar in all experimental groups and
inhibition of Akt did not induce a detectable increase in apoptosis
of T. gondii-infected cells (not shown). Akt inhibitor IV not only
induced a significant decrease in the numbers of parasites per 100
HBMEC at 24 h but it also caused a profound reduction in the
numbers of T. gondii-containing vacuoles per 100 HBMEC
(p,0.01) (Figure 2A, Figure S1A). Similar results were obtained
Figure 1. T. gondii induces Akt activation via PI3K signaling in non-hematopoietic cells. A, Primary HBMEC were challenged with type I
(RH) or type II (ME49) strains of T. gondii for the indicated time points. Cell lysates were used to probe for total Akt and phospho-Ser473 Akt by
immunoblot. B, C, Mouse endothelial cells (mHEVc; B) and human retinal pigment epithelial cells (RPE, C) were challenged with RH T. gondii followed
by assessment of Akt phosphorylation. D, HBMEC were challenged with either live or killed T. gondii. Cell lysates were subject to immunoblotting as
indicated. E, HBMEC were transiently transfected with a plasmid encoding PH-Akt-GFP. Cells treated with or without LY294002 (20 mM) for 1 h prior to
challenge with T. gondii-RFP. Cells were examined by immunofluorescence at 5 min post-challenge to examine accumulation of PH-Akt-GFP around
the parasites. F, HBMEC were incubated with LY294002 or vehicle for 1 h prior to challenge with T. gondii. Densitometry data represent means6 SEM
of 4 experiments. A vertical line was inserted between densitometry data from control and LY294002-treated cells to indicate that band densities
from infected cells treated with or without LY294002 are compared to bands from their respective uninfected cells, which were given an arbitrary
number of 1. G, HBMEC were transiently transfected with control siRNA or PI3K p110a siRNA. Cells expressing either control siRNA or PI3K p110a
siRNA were challenged with T. gondii 48 h after transfection. Cell lysates were subject to immunoblotting as indicated. Densitometry data are shown
as above and represent means 6 SEM of 3 experiments. Results shown are representative of 3–4 independent experiments.
doi:10.1371/journal.ppat.1003809.g001
Toxoplasma, EGFR-Akt and Autophagy
PLOS Pathogens | www.plospathogens.org 3 December 2013 | Volume 9 | Issue 12 | e1003809
Figure 2. Blockade of Akt induces accumulation of the autophagy protein LC3 around the parasite, vacuole-lysosome fusion and
killing of T. gondii dependent on the autophagy proteins. A, HBMEC, mHEVc and human RPE cells were incubated with or without Akt
inhibitor IV (1.25 mM) for 1 h prior to challenge with T. gondii. Monolayers were examined by light microscopy 2 h and 24 h post-challenge. B, HBMEC
were transfected with control siRNA or Akt siRNA. Cells were then challenged with T. gondii 48 h after transfection. Monolayers were examined
microscopically 24 h post-challenge. C, RAW 264.7 were incubated with or without Akt inhibitor IV for 1 h prior to challenge with T. gondii.
Monolayers were examined by light microscopy 2 h and 24 h post-challenge. D, mHEVc-LC3-EGFP cells were incubated with or without Akt inhibitor
IV followed by challenge with T. gondii-RFP. Monolayers were examined by fluorescence microscopy 5 h post-challenge. Arrowheads indicate
accumulation of LC3 around the parasite. E, HBMEC were treated with or without Akt inhibitor IV for 1 h prior to challenge with T. gondii (T) and then
Toxoplasma, EGFR-Akt and Autophagy
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with mouse endothelial cells (mHEVc; Figure 2A, Figure S1A) and
human RPE cells (p,0.01) (Figure 2A, Figure S1A). Not only
pharmacologic inhibition of Akt but also Akt knockdown in
HBMEC reduced the parasite load and the number of T. gondii-
containing vacuoles (p,0.01) (Figure 2B, Figure S1A). The
vacuoles that persisted after Akt knockdown had similar numbers
of parasites as those from control cells (Figure S1B). These results
indicate that blockade of Akt caused parasite killing. T. gondii
infection causes Akt activation in macrophages [31]. Similar to
endothelial and epithelial cells, treatment with Akt inhibitor IV
caused anti-T. gondii activity in the mouse macrophage line RAW
264.7 and in mouse microglia line BV-2 (p,0.01) (Figure 2C and
not shown). These findings revealed an important role of Akt
activation in promoting survival of T. gondii within host cells.
T. gondii survives within mammalian cells by avoiding delivery of
the lysosomal contents into the parasitophorous vacuole [32–34].
Akt is a negative regulator of autophagy [35], a cellular
mechanism that results in lysosomal degradation and killing of
T. gondii [13–15]. First, we examined T. gondii-infected cells after
Akt inhibition to determine the distribution of LC3, a protein
associated with the autophagosome membrane. mHEVc-LC3-
EGFP cells were treated with or without Akt inhibitor IV and
challenged with T. gondii-RFP. Akt inhibitor IV led to significant
accumulation of LC3 around the parasite (p,0.01) (Figure 2D).
Electron microscopy studies were performed since a double
membrane isolation membrane that encircles portions of cyto-
plasm or organelles is formed during autophagy [16]. Indeed, a
double membrane structure was noted around the parasitophor-
ous vacuole membrane in HBMEC treated with Akt inhibitor IV
(Figure 2E). Next, we examined the effects of Akt inhibition on the
distribution of the late endosomal/lysosomal molecule LAMP-1.
Endothelial cells were incubated with or without Akt inhibitor IV,
challenged with T. gondii-YFP followed by staining with anti-
LAMP-1 mAb. Treatment with Akt inhibitor IV resulted in a
remarkable increase in the percentage of parasites surrounded by
LAMP-1 (p,0.01) (Figure 2F). To explore whether the killing of
T. gondii during inhibition of Akt is dependent on the autophagy
machinery, we examined the effects of knockdown of the
autophagy proteins Beclin 1 or Atg7 on T. gondii survival.
Transfection with Beclin 1 siRNA or Atg7 siRNA effectively
diminished expression of Beclin 1 or Atg7 respectively (Figure 2G,
H). Endothelial cells transfected with Beclin1 siRNA or Atg7
siRNA were incubated with or without Akt inhibitor and
challenged with T. gondii. Cells transfected with Beclin1 siRNA
(Figure 2G) or Atg7 siRNA (Figure 2H) were unable to control the
parasite in the presence of the Akt inhibitor IV. Since autophago-
somes deliver their contents to lysosomes for degradation, we
examined the role of lysosomal degradation in killing of T. gondii
utilizing the lysosomal protease inhibitors leupeptin and pepstatin.
mHEVc and RPE cells were treated with or without Akt inhibitor
IV and infected with T. gondii. 1 h post infection cells were treated
with or without leupeptin plus pepstatin. Lysosomal protease
inhibitors impaired the anti-T. gondii activity induced by Akt
inhibition (p,0.05) (Figure 2I and not shown). Finally, the anti-T.
gondii activity induced by Akt inhibitor IV in mouse microglia and
human RPE cells was impaired by 3-methyl adenine, an inhibitor
of autophagy (p,0.05) (Figure 2J and not shown). Taken together,
these results indicate that T. gondii-induced Akt activation is critical
to promote parasite survival because it prevents killing of T. gondii
dependent on the autophagy pathway and lysosomal protease
activity.
T. gondii infection induces EGFR activation in mammalian
cells that prevents autophagy pathway dependent killing
of the parasite
Akt activation classically occurs downstream of cell membrane
receptors that include growth factor receptors, G protein-coupled
receptor (GPCR) and TLR [36]. To examine the role of GPCR in
Akt activation in non-hematopoietic cells, HBMEC were incubat-
ed with or without Pertussis toxin (PTx), an inhibitor of GPCR
signaling, followed by challenge with T. gondii tachyzoites. PTx did
not affect the initial percentage of infected cells (data not shown).
Incubation with PTx decreased basal Akt phosphorylation.
However, PTx did not prevent the increased Akt phosphorylation
induced by T. gondii (Figure 3A) indicating that T. gondii can
activate Akt independently of GPCR signaling. In contrast, PTx
inhibited Akt activation induced by lysophosphatidic acid (LPA), a
GPCR ligand [37] (Figure 3A). To examine the potential role of
TLR signaling in Akt, MyD88 was knocked-down in HBMEC
using siRNA. Knockdown of MyD88 did not affect T. gondii-
induced Akt activation (Figure 3B). In contrast, as assessed by
FACS, the ICAM-1 upregulation induced by LPS (1 mg/ml) in
HBMEC was inhibited in cells transfected with MyD88 siRNA
compared to those transfected with control siRNA (cMFI: Control
siRNA=10,68261,053; MyD88 siRNA=3,2506527; p,0.05).
These studies indicate that GPCR and TLR are unlikely to play a
major role in Akt phosphorylation induced by T. gondii in non-
hematopoietic cells.
Relevant to the possibility of activation of growth factor
receptors during T. gondii-host cell interaction is the fact that host
cell invasion by T. gondii requires the secretion of parasite
micronemal proteins (MICs) with the potential to activate such
receptors [38]. MICs exist as multiprotein complexes, the most
important being MIC1/4/6, MIC3/8, MIC2/M2AP, and a
complex of the microneme protein TgAMA1 with rhoptry neck
proteins RON2/RON4/RON6/RON8 [39–41]. MIC3, MIC6
and MIC8 have multiple domains with homology to EGF [42] and
are therefore termed EGF-MICs. As an initial experiment, we
examined whether T. gondii induces autophosphorylation at 2
major tyrosine residues of EGFR (1068 and 1148). HBMEC were
incubated with RH T. gondii tachyzoites followed by determination
of EGFR phosphorylation by immunoblot. T. gondii induced
activation of EGFR, as indicated by phosphorylation of tyrosine
residue 1068 (Figure 4A). Moreover, the parasite caused
phosphorylation of tyrosine residue 1148, a site that appears to
be phosphorylated only by ligand binding to EGFR [43]
(Figure 4A). Similar results were found using the ME49 strain of
processed for electron microscopy at 5 h post-challenge. Images at the bottom represent magnification of the areas within the boxes. Arrow
indicates the PVM; arrowhead indicates the double membrane structure around the vacuole. F, Control or Akt inhibitor IV-treated HBMEC were
challenged with T. gondii-YFP. Expression of LAMP-1 was examined by fluorescent microscopy 8 h post-challenge. Arrowheads indicate accumulation
of LAMP-1 around the parasite G, H, mHEVc cells were transfected with Beclin 1 siRNA (G), Atg7 siRNA (H) or control siRNA. After 48 h, cells were
treated with or without Akt inhibitor IV for 1 h prior to challenge with T. gondii. Monolayers were examined by light microscopy at 24 h. I, mHEVc
were treated with or without Akt inhibitor IV and infected with T. gondii. 1 h post infection cells were treated with or without leupeptin plus
pepstatin (Lys inhibitors). Monolayers were examined microscopically 24 h post-challenge. J, Mouse microglia were incubated with or without Akt
inhibitor IV. 3-methyl adenine (3MA; 10 mM) or vehicle were added 2 h post-challenge with T. gondii. Monolayers were examined microscopically
24 h post-challenge. Results are shown as the mean 6 SEM and are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g002
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T. gondii (not shown). Immunoblot analysis revealed that EGFR
activation occurred in HBMEC upon challenge with viable but
not killed parasites (Figure 4B). EGFR autophosphorylation was
not only observed in endothelial cells but also in human RPE cells
and mouse microglia incubated with T. gondii (Figure 4C, 4D).
Thus, T. gondii causes EGFR activation in various mammalian
cells.
Next, we examined whether EGFR signaling is involved in
activation of Akt triggered by T. gondii. Endothelial cells were
transiently transfected with a plasmid that encodes either control
siRNA or EGFR siRNA followed by challenge with T. gondii. The
efficiency of EGFR knockdown was confirmed by immunoblot
(Figure 5A). EGFR knockdown ablated the ability of T. gondii to
induce activation of Akt at all time points tested (Figure 5A). Next,
we explored the role of EGFR signaling on Akt activation in
professional phagocytes. Mouse microglia were treated with
vehicle or AG1478, a pharmacological inhibitor of EGFR kinase
activity, followed by challenge with T. gondii. Inhibition of EGFR
kinase activity ablated parasite-induced Akt activation in mouse
microglia (Figure 5B).
We assessed whether EGFR activation affects T. gondii survival
within host cells. HBMEC were treated with vehicle or AG1478
Figure 3. Role of G protein coupled receptors and MyD88 in T. gondii-induced Akt phosphorylation. A, HBMEC were treated with or
without pertussis toxin (PTx; 100 ng/mL) for 4 h prior to challenge with T. gondii. Cell lysates were obtained at 5, 15 or 30 min post-incubation with T.
gondii and used to examine total Akt and phospho-Akt serine 473 by immunoblot. Densitometry data represent means 6 SEM of 3 experiments. A
vertical line was inserted between densitometry data from control and PTx-treated cells to indicate that band densities from infected cells treated
with or without PTx were compared to bands from their respective uninfected cells, which were given an arbitrary number of 1. HBMEC were also
treated with or without LPA (10 mM) in the presence or absence of PTx. Cell lysates were obtained at 5 min and subjected to immunoblotting. B,
HBMEC were transfected with MyD88 siRNA or control siRNA followed by challenge with T gondii after 48 h. Cell lysates were used to examine total
Akt and phospho-serine 473 Akt by immunoblot. Results shown are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g003
Figure 4. T. gondii infection induces EGFR activation in mammalian cells. A, HBMEC cells were challenged with RH T. gondii and cell lysates
were obtained to probe for total EGFR, phospho-tyrosine 1068 EGFR and phospho- tyrosine 1148 EGFR by immunoblot. B, HBMEC were challenged
with live vs killed tachyzoites. Total EGFR and phospho-tyrosine 1068 EGFR expression was examined by immunoblot. C, D, Human RPE cells (C) and
mouse microglia (D) were challenged with RH T. gondii and total EGFR and phospho-tyrosine 1068 EGFR expression was examined by immunoblot.
Results shown are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g004
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followed by challenge with T. gondii. While AG1478 did not
affect the percentage of infected cells at 2 h, AG1478 caused a
marked reduction in the percentage of infected cells 24 h post-
challenge (p,0.05) (Figure 6A). In addition, there was a
significant reduction in the numbers of parasites per 100
endothelial cells (p,0.01) (Figure 6A). Similar results were
obtained whether HBMEC or human retinal endothelial cells
were infected with RH or ME49 strains of T. gondii (not shown).
The role of EGFR in affecting parasite survival was confirmed
with a genetic approach since knockdown of EGFR in human
RPE cells resulted in enhanced killing of T. gondii (p,0.01)
(Figure 6B). Similar to the studies of blockade of Akt, inhibition
of EGFR signaling not only reduced the percentages of infected
cells but also caused a reduction in the numbers of vacuoles per
100 cells without affecting the numbers of parasites in the
vacuoles that persisted after EGFR blockade (not shown). The
effects of EGFR signaling inhibition were not restricted to non-
hematopoietic cells since mouse bone marrow-derived macro-
phages also acquired anti-T. gondii activity when treated with
AG1478 (p,0.05) (Figure 6C). To further explore the role of
EGFR in the survival of T. gondii, we took a reverse approach
and infected parental CHO cells, known to be EGFR null [44],
and CHO cells expressing human EGFR (CHO-EGFR). A
reduction in the percentage of infected cells and a reduction in
parasite load at 24 h were observed in parental CHO cells
compared to CHO-EGFR cells (p,0.05) (Figure 6D). These
findings revealed an important role of EGFR in promoting Akt
activation and T. gondii survival within host cells.
We investigated whether T. gondii killing induced by inhibition
of EGFR is dependent on autophagy proteins. Knockdown of
EGFR in mHEVc cells or treatment of these cells with AG1478
resulted in an enhanced accumulation of LC3 and LAMP-1
around the parasite (p,0.05) (Figure 6E and 6F). Moreover,
silencing of Beclin 1 or Atg7 prevented induction of anti-T. gondii
activity in endothelial cells subjected to EGFR knock-down or
treated with AG1478 (p,0.01) (Figure 6G and 6H). Taken
together, activation of EGFR signaling promoted survival of T.
gondii within host cells by inhibiting autophagy protein-dependent
killing of the parasite.
T. gondii MICs can induce phosphorylation of EGFR and
Akt in host cells
EGFR ligands exist as precursors transmembrane proteins that
are shed from the plasma membrane by members of the ADAM (a
disintegrin and metalloprotease) family of zinc-dependent metal-
loproteases [45]. This results in an autocrine or paracrine EGFR
activation, a phenomenon that explains how proteins such GPCR
activate EGFR [45]. We explored whether EGFR activation
triggered by T. gondii could be due to this mechanism of autocrine/
paracrine signaling. HBMEC were treated with GM6001, a broad
spectrum ADAM inhibitor, followed by challenge with T. gondii.
GM6001 did not affect the percentage of infected cells (data not
shown) and did not prevent the ability of T. gondii to induce EGFR
activation (Figure 7A). Moreover, EGFR phosphorylation after T.
gondii infection took place despite incubation with PTx (Figure 7B).
These findings suggest that ADAM- and GPCR-dependent EGFR
activation do not play a major role in EGFR phosphorylation
induced by T. gondii.
As stated above, MIC3, MIC6, MIC8 have multiple domains
with homology to EGF [42]. MIC7 and MIC9 also express EGF-
like domains but these MICs have poor or no expression in
tachyzoites [42]. We examined the effect of deficiency of MICs on
the ability to induce activation of EGFR and Akt. HBMEC were
infected with wild type (WT), MIC1 ko (lacks MIC1, resulting in
deficient secretion of MIC6 [46]), MIC3 ko (lacks MIC3), MIC1-3
ko (lacks MIC6 secretion and MIC3) parasites followed by
determination of EGFR and Akt activation. These MIC ko
parasites still express MIC8 (MIC8 deficiency results in parasites
that are unable to infect mammalian cells). The multiplicity of
infection was adjusted so that the initial percentages of infected
HBMEC were similar for all strains of the parasite (Figure 8A).
Compared to WT T. gondii, MIC1 ko and MIC3 ko parasites
caused a partial reduction in EGFR and Akt phosphorylation
(p,0.05) (Figure 8B, 8C). MIC1-3 ko parasites caused further
decrease in EGFR and Akt phosphorylation compared to MIC1
ko and MIC3 ko parasites (p,0.05) (Figure 8B, 8C). However,
even in cells infected with MIC1-3 ko parasites the reduction in
EGFR and Akt phosphorylation was not complete. MIC1-3 ko
parasites still express MIC8, a molecule that has EGF-like
Figure 5. EGFR mediates Akt activation induced by T. gondii. A, mHEVc cells were transfected with control siRNA or EGFR siRNA. Expression of
EGFR and actin were assessed by immunoblot 48 h post-transfection. mHEVc cells expressing either control siRNA or EGFR siRNA were challenged
with T. gondii. Cell lysates were used to examine the expression total Akt or phospho-Ser473 Akt by immunoblot. B, Mouse microglia were treated
with or without AG1478 (1 mM) 1 h prior to challenge with T. gondii. Cell lysates were used to examine the expression total Akt or phospho-Ser473
Akt by immunoblot. Densitometry data represent means 6 SEM of 3 experiments. A vertical line was inserted between densitometry data from
control siRNA and EGFR siRNA or control and AG1478-treated cells to indicate that band densities from infected control cells or infected cells
subjected to EGFR blockade were compared to bands from their respective uninfected cells, which were given an arbitrary number of 1. Results
shown are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g005
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domains. We used conditional MIC8 knockout T. gondii previously
generated using a tetracycline-inducible system to explore the
potential role of MIC8 in signal activation [47]. Incubation of
these parasites with anhydrotetracycline (ATc) results in almost
complete ablation of MIC8 [47]. Parasites previously grown in the
absence or presence of ATc were incubated with HBMEC. We
could not detect an appreciable decrease in Akt phosphorylation in
cells exposed to MIC8 deficient parasites (Figure S2). To further
explore the role of MICs in the activation of EGFR and Akt,
HBMEC were incubated with Pichia pastoris-derived MIC3.
Although the EGF-like domains alone do not appear to promote
the adhesion of MIC3 to mammalian cells [48], it was still possible
that MIC3 could cause EGFR and Akt activation. Indeed,
compared to recombinant MIC4 (a control that does not express
EGF-like domains) incubation with recombinant MIC3 caused
enhanced phosphorylation of EGFR and Akt in HBMEC
(Figure 8D, 8E). Moreover, incubation with E. coli-derived
MIC6 but not M2AP caused EGFR-Akt phosphorylation
(Figure 8D, 8E). This response was unlikely to be mediated by
LPS since M2AP and MIC6 preparations had similar concentra-
tions of LPS (12 ng/ml and 12.4 ng/ml respectively). In addition,
LPS at concentrations between 10–1,000 ng/ml failed to induce
EGFR phosphorylation in HBMEC (not shown). Taken together,
EGF-MICs (MIC3 and MIC6) can induce EGFR-Akt activation
and parasites deficient on these MICs have diminished capacity to
activate EGFR and Akt.
Figure 6. Blockade of EGFR induces accumulation of the autophagy protein LC3 around the parasite, vacuole-lysosome fusion and
killing of T. gondii dependent on the autophagy proteins. A, HBMEC were incubated with AG1478 (1 mM) 1 h prior to challenge with T. gondii.
Monolayers were examined by light microscopy at 2 and 24 h. B, Human RPE cells transfected with either EGFR or control siRNA were challenged with
T. gondii followed by examination of monolayers by light microscopy at 24 h. C, Mouse bone marrow-derived macrophages were incubated with
AG1478 and challenged with T. gondii. Monolayers were examined by light microscopy at 2 and 24 h. D, Parental CHO and CHO-EGFR cells were
challenged with RH T. gondii. Monolayers were examined microscopically 2 h or 24 h post-challenge. E, mHEVc-LC3-EGFP cells transfected with
control siRNA or EGFR siRNA were challenged with T. gondii-RFP. Monolayers were examined by fluorescence microscopy 5 h post-challenge to
determine the percentage of endothelial cells with LC3 accumulation around the parasite. F, HBMEC cells treated with or without AG1478 were
challenged with either T. gondii-YFP. Expression of LAMP-1 was examined by fluorescent microscopy 8 h post-challenge. The percentages of
endothelial cells with LAMP-1 accumulation of around the parasite were determined. G, H, mHEVc cells transfected with Beclin1 siRNA (G) or Atg7
siRNA (H) were transfected with EGFR siRNA or treated with or without AG1478 followed by challenge with T. gondii. Monolayers were examined by
light microscopy 24 h post-challenge. Results are shown as the mean 6 SEM and are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g006
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EGFR signaling and MICs impair autophagic killing of T.
gondii
Cells stimulated with CD154 (CD40 ligand) exhibit accumula-
tion of LC3 around T. gondii and killing that is dependent on
autophagy proteins [13–15]. We examined whether targeting of
the parasite by LC3+ structures in CD154-treated cells can be
affected by EGFR signaling. Endothelial cells were treated with or
without CD154 followed by challenge with T. gondii in the
presence or absence of EGF. EGF did not affect the initial
percentage of infected cells (not shown). As previously reported
[15], CD154 caused accumulation of LC3 around T. gondii
(Figure 9A). Targeting of parasites by LC3+ structures was
inhibited in cells that were exposed to EGF (p,0.05) (Figure 9A),
The effect of EGF was specific since addition of AG1478 to cells
treated with EGF restored LC3 accumulation around T. gondii
(Figure 9A). Similar results were obtained using rapamycin, a well-
described stimulator of autophagy (Figure 9B). Next, we explored
the role of MICs on the distribution of LC3+ structures in
Figure 7. Role of metalloproteinases and G protein coupled receptors in T. gondii-induced EGFR phosphorylation. HBMEC were
treated with or without GM6001 (10 mM) for 1 h prior to challenge with T. gondii (A) or with Pertussis Toxin (PTx; 100 ng/ml) for 4 h prior to parasite
challenge (B). Cell lysates were used to examine total EGFR and phospho-tyrosine 1068 EGFR by immunoblot. Densitometry data represent means 6
SEM of 3 experiments. A vertical line was inserted between densitometry data from control and GM6001- or PTX-treated cells to indicate that band
densities from infected cells treated with or without these inhibitors are compared to bands from their respective uninfected cells, which were given
an arbitrary number of 1. Results shown are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1003809.g007
Figure 8. T. gondiimicronemal proteins appear to induce EGFR and Akt activation. A, B, C HBMEC were challenged with DHx (WT), MIC1 ko,
MIC3 ko, MIC1-3 ko T. gondii at MOIs that yielded similar percentages of infected cells (A). Cell lysates were obtained and used to examine total EGFR
and phospho-tyrosine 1068 EGFR (B) or total Akt and phospho-Ser 473 Akt (C) by immunoblot. HBMEC were incubated with 10 nM of recombinant
MIC4, MIC3, M2AP or MIC6 for 15 minutes followed by examination of total EGFR and phospho-tyrosine 1068 EGFR (D) or total Akt and phospho-
Ser473 (E) by immunoblot. Densitometry data represent means 6 SEM of 4 experiments. Band densities from infected cells or cells treated with MICs
were compared to bands from uninfected or untreated cells (Un), which were given an arbitrary number of 1. Results shown are representative of 4
independent experiments.
doi:10.1371/journal.ppat.1003809.g008
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endothelial cells treated with CD154. Endothelial cells were
treated with or without CD154 followed by challenge with WT,
MIC1 ko, MIC3 ko, MIC1-3 ko and their respective comple-
mented parasites. Infection with MIC1 ko, MIC3 ko or MIC1-3
ko parasites induces a partial decrease in EGFR-Akt activation (see
Figures 8B, 8C). Indeed, in control endothelial cells (no CD154
treatment) there were no differences in the low level LC3
accumulation around the parasites (Figure 9C). After treatment
with CD154, enhanced accumulation of LC3 around the parasites
was similar in endothelial cells infected with WT, MIC1 ko or
MIC3 ko parasites (Figure 9C). In contrast, cells infected with
MIC1-3 ko parasites (the strain that was the weakest inducer of
EGFR-Akt activation) exhibited a significant further increase in
LC3 accumulation (p,0.05) (Figure 9C). These results were
specific because the phenotype was lost in the complemented
strain of T. gondii (MIC1-3 ko+MIC1-3) (Figure 9C). Examination
of the parasite load revealed that the loads of MIC1 ko, MIC3 ko
and MIC1-3 ko parasites were not significantly different from
those of WT parasites in control endothelial cells (no CD154
treatment) (Figure 9D). When cells were treated with CD154,
MIC1-3 ko T. gondii displayed increased susceptibility to CD154-
induced anti-T. gondii activity (p,0.05) (Figure 9D). Similar to the
studies of LC3 expression, the phenotype of MIC1-3 ko parasites
was lost in the complemented strain (MIC1-3 ko+MIC1-3)
(Figure 9D). Next, we examined whether increased killing of
MIC1-3 ko parasites was observed in cells treated with another
autophagy inducer (rapamycin) or in cells treated with IFN-c, a
cytokine that triggers anti-T. gondii activity independently of
autophagic degradation [13–15]. Similar to CD154-stimulated
cells, MIC1-3 ko parasites were more susceptible to rapamycin-
induced killing (p,0.05) (Figure 9E). Moreover, in contrast to the
results obtained with CD154-stimualtion, anti-T. gondii activity
induced by IFN-c/TNF-a was similar in all parasite strains tested
including MIC1-3 ko T. gondii (Figure 9F). Finally, we explored the
effects of recombinant MICs on CD154-induced killing of MIC1-3
ko T. gondii. In initial experiments, recombinant MICs did not
affect the load of T. gondii in non-activated (control) endothelial
cells or cells treated with IFN-c/TNF-a (not shown). Next, control
or CD154-activated endothelial cells were challenged with WT or
MIC1-3 ko parasites in the presence of absence of recombinant
MICs. Whereas treatment of endothelial cells with MIC4 and
M2AP did not affect the load of WT or MIC1-3 ko parasites in
CD154-activated cells, treatment with MIC3 or MIC6 inhibited
CD154-induced T. gondii activity (p,0.05) (Figure 9G). Moreover,
the phenotype of MIC1-3 ko parasites of increased susceptibility to
CD154-mediated anti-T. gondii activity was lost in the presence of
either MIC3 or MIC6 since the loads of WT and MIC1-3 ko
parasites were no longer different in cells treated with these EGF-
MICs (Figure 9G). Taken together, our findings indicate that
EGFR, MIC3 and MIC6 negatively regulate autophagic killing of
T. gondii.
Discussion
Avoidance of lysosomal degradation is pivotal for the survival of
numerous intracellular pathogens including T. gondii. Our studies
indicate that, in addition to exclusion of type I transmembrane
proteins from the PVM, T. gondii also activates EGFR-Akt
signaling in the host cell to prevent targeting of the parasite by
LC3+ structures and pathogen killing that is dependent on
autophagy proteins and lysosomal protease activity. Thus, these
studies identified EGFR-Akt signaling as a pathway critical for
pathogen survival. In addition, they suggest that EGF-MICs may
be involved in pathogen virulence not only by allowing parasite
invasion of host cells but also by activating host cell signaling that
counter-regulates autophagy.
Various bacteria and viruses encode virulence factors that
impair the function of autophagy proteins and as a result, avoid
their degradation via the autophagy pathway [18–24]. It has been
suggested that HIV-1 and M. tuberculosis may prevent autophagic
degradation by affecting signaling cascades that regulate the
autophagy pathway [25,26]. Our studies indicate that indeed a
pathogen can act at the level of a regulatory pathway to avoid its
degradation by the autophagy machinery. Relevant to our findings
is the report that HIV-1 tat impairs autophagy by stimulating
counter-regulatory cascades (Akt and STAT3), although these
studies did not examine whether these pathways would prevent
lysosomal degradation of the virions [49].
Our studies indicate that T. gondii-induced EGFR activation is a
major event upstream of Akt phosphorylation in endothelial and
RPE cells, a finding consistent with the important role of EGFR
and other growth factor receptors as activators of Akt signaling
[36,50]. PI3K is a classical link between growth factor receptors
and Akt activation. However, in contrast inhibition of EGFR
signaling, the effect of PI3K inhibition on Akt activation appeared
to be more transient. These findings may be explained by the fact
that, besides PI3K, there are additional activators of Akt that
might be engaged by growth factor receptors [51]. T. gondii has
been reported to activate Akt in macrophages, a phenomenon that
was inhibited by PTx [31]. Our studies indicate that EGFR also
contributes to Akt activation in macrophages/microglia since the
parasite caused EGFR autophosphorylation and inhibition of
EGFR signaling impaired parasite-induced Akt activation. More-
over, not only activation of Akt but also activation of EGFR in
endothelial cells, RPE cells and macrophages/microglia prevented
killing of T. gondii dependent on autophagy proteins and lysosomal
enzymes. The fact that Akt activation has been linked to inhibition
of apoptosis of T. gondii-infected cells [31] raises the possibility that
parasite-induced EGFR - Akt signaling may not only promote
parasite survival by preserving the non-fusogenic nature of the PV
but also by avoiding death of infected cells subjected to pro-
apoptotic signals. While EGFR is a central mediator of Akt
activation in the early stages after T. gondii, Akt phosphorylation
has recently been reported at 24 h post-infection with the parasite
[52]. This raises the possibility that T. gondii may also activate Akt
through additional mechanisms besides parasite engagement of
EGFR.
Although T. gondii causes EGFR - Akt activation and these
signaling molecules have been shown to inhibit autophagy
[35,53,54], T. gondii does not appear to prevent autophagosome
formation in infected cells. Indeed, large LC3+ structures were
readily detected within infected cells during early stages post-
infection (see Figure 2D), a finding previously reported in host cells
at 24 h post-infection [55]. Moreover, there is no decrease in the
levels of LC3 II (the lipidated form of LC3 that associates with the
autophagosome membrane) during the early stages of infection
(Muniz-Feliciano and Subauste, unpublished observations). In fact,
T. gondii has been reported to increase LC3 II levels and
autophagosome formation in host cells at 24 h post-infection,
presumably as an attempt to gain access to nutrients [55]. Our
studies indicate that while global autophagy did not appear to be
inhibited by T. gondii, engagement of EGFR impaired targeting of
the PV by LC3+ structures. Future studies that identify how
autophagosomes target the PV will likely shed light on the
molecular mechanism by which EGFR - Akt diminish autophagic
targeting of the parasite.
Various pathogens can target EGFR. Pseudomonas aeruginosa and
Helicobacter pylori can cause EGFR phosphorylation that is
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mediated by the release of membrane-bound EGF ligands and
transactivation of EGFR [56,57]. Klebsiella pneumonia causes EGFR
activation that appears to be dependent on bacterial capsule
polysaccharide engagement of TLR4 and subsequent Src-
dependent EGFR activation [58]. In addition, proteins from
oncogenic viruses activate EGFR to mediate transformation [59].
Much less is known on whether microbial products can directly
engage and activate EGFR. It has been suggested that H. influenza
may activate EGFR through the presence of bacterial-derived
molecules with EGF-like properties [60]. Uptake of Influenza A
virus causes EGFR activation, a process that may be dependent on
multivalent binding of hemagglutinin to sialic acids present on
EGFR or ganglioside GM1 leading to aggregation of rafts,
clustering of EGFR and its activation [61]. Our studies suggest
that EGF-MICs play a role in mediating EGFR-Akt activation of
host cells and prevention of parasite killing since: recombinant
EGF-MICs (MIC3 and MIC6) induce EGFR-Akt activation while
MICs that lack EGF domains do not cause appreciable
phosphorylation of EGFR and Akt; EGFR signaling inhibits
LC3 accumulation around T. gondii; parasites deficient in 2
EGF-MICs (MIC3 and MIC6: MIC1-3 ko parasites) cause
markedly impaired EGFR-Akt activation and exhibit increased
encasing by LC3+ structures as well as killing in cells treated with
autophagy stimulators; MIC3 and MIC6 impair parasite killing
mediated by the autophagy pathway.
It was interesting to note that MIC1-3 ko parasites are not
targeted by LC3+ structures and are not more likely to be killed in
unstimulated cells despite the markedly weakened EGFR-Akt
signaling. MIC1-3 ko parasites only display increased susceptibility
to autophagic targeting and killing when autophagy is stimulated
by CD154 or rapamycin. Of relevance to our findings, other
studies support the existence of signaling thresholds that need to be
achieved in order for autophagy to take place [62,63]. For
example, in Drosophila both the Ret-like receptor tyrosine kinase
Stitcher (Stit) and insulin receptor (InR) are required for cell
growth and proliferation through the PI3K-I/TORC1 pathway in
the wing disc [63]. A decrease in either Stit or InR signaling
diminishes TORC1 activity and suppresses growth [63]. However,
this decrease in TORC1 activity is not sufficient to trigger
autophagy in the wing [63]. Autophagy only takes place when
Figure 9. EGFR and T. gondiimicronemal proteins modulate CD40-induced recruitment of LC3 around T. gondii and parasite killing.
A, hmCD40 mHEVc expressing LC3-EGFP were treated with or without CD154 followed by challenge with T. gondii-RFP in the presence or absence of
EGF (50 ng/ml) or AG1478 (1 mM). LC3 accumulation around T. gondii was assessed by immunofluorescence. B, mHEVc-LC3-EGFP cells were infected
with T. gondii-RFP. Cells were treated with vehicle or rapamycin (1 mM) 2 h after challenge with T. gondii in the presence or absent of EGF or AG1478.
Recruitment of LC3 around the parasite was examined at 5 h after challenge with T. gondii. C, hmCD40 mHEVc-LC3-EGFP cells were treated with or
without CD154 followed by challenged with WT, MIC1 ko, MIC1 ko+MIC1, MIC3 ko, MIC3 ko+MIC3, MIC1-3 ko, MIC1-3 ko+MIC1-3 tachyzoites. LC3
accumulation around the parasite was examined by fluorescence microscopy 5 h post-challenge. D, hmCD40 mHEVc-LC3-EGFP treated with or
without CD154 were challenged with WT, MIC1 ko, MIC1 ko+MIC1, MIC3 ko, MIC3 ko+MIC3, MIC1-3 ko or MIC1-3 ko+MIC1-3 tachyzoites. Parasite load
was examined 24 h post-challenge. E, HBMEC cells were challenged with WT, MIC1 ko, MIC3 ko, MIC1-3 ko tachyzoites followed by treatment with
vehicle or rapamycin. Parasite load was examined 24 h post-challenge. F, HBMEC treated with or without CD154 or IFN-c/TNF-a were challenged with
WT, MIC1 ko, MIC3 ko, MIC1-3 ko tachyzoites. Monolayers were examined microscopically at 24 h post-challenge. G, hmCD40 mHEVc cells treated
with or without CD154 were infected with either WT or MIC1-3 ko tachyzoites in the presence of complete medium (CM) alone or medium plus MIC3,
MIC4, M2AP or MIC6 (all 10 nM). Parasite load was determined microscopically 24 h post challenge. Results shown are representative of 3–4
independent experiments.
doi:10.1371/journal.ppat.1003809.g009
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both Stit and InR are impaired [63]. It was proposed that the
simultaneous inactivation of Stit and InR reduces PI3K-I activity
and TORC1 signaling below a critically low level at which
autophagy in the wing can no longer be prevented [63]. Given
that the EGFR-Akt pathway inhibits autophagy by regulating
TORC1 activity, a similar phenomenon could be at play in the
case of T. gondii infection. The reduction in EGFR-Akt observed in
cells infected with MIC1 ko or MIC3 ko parasites does not
translate in increased autophagic killing of these parasites either in
unstimulated cells or in cells treated with stimulators of autophagy.
The further reduction in EGFR-Akt signaling observed in cells
infected with MIC1-3 ko may still be sufficient to prevent
autophagic killing in unstimulated cells but results in enhanced
killing in cells treated with autophagy stimulators. Finally, further
inhibition of EGFR-Akt signaling (by genetic or pharmacological
approaches) triggers autophagic targeting of T. gondii even in
unstimulated cells. Thus, our studies suggest that the effects of
MIC deficiency on the levels of EGFR-Akt activation likely
explain the differences in outcome observed after infection. Taken
together, in addition to being key for invasion of host cells, EGF-
MICs (MIC3 and MIC6) contribute to the induction of a signaling
cascade within these cells that is required to avoid lysosomal
degradation of the parasite.
While MIC1-3 ko parasite exhibited a marked defect in EGFR-
Akt activation in host cells, phosphorylation of these molecules still
took place. Although we cannot rule out a role of MIC8 in
activation of this cascade, it appears that the residual ability of
MIC1-3 ko parasites to activate EGFR-Akt may not be explained
by their expression of MIC8 (an EGF-MIC). Conditional MIC8 ko
parasites did not exhibit a noticeable defect in signal activation in
host cells. These findings are likely explained by the fact that
MIC8 ko parasites do not exhibit defects in attachment to host
cells and they secrete MICs [47]. The presence of an additional
mechanism of EGFR-Akt activation that normally cooperates with
MIC-dependent EGFR signaling may explain why MIC1-3 ko T.
gondii have residual capacity to activate the EGFR-Akt pathways.
T. gondii is very successful as a pathogen and utilizes various
strategies to manipulate host cell signaling to ensure its survival
[64–67]. Here we report that the parasite activates EGFR - Akt to
maintain the non-fusogenic nature of PV a process that appears to
be dependent at least in part on EGF-MICs. These findings may
be of therapeutic relevance since various inhibitors of EGFR are
being used for treatment of cancer. The fact that EGFR inhibition
induced parasite killing in cells not treated with immune
activators, raises the possibility that this approach may be effective
even in immunocompromised hosts.
Materials and Methods
Mammalian cells
Primary human brain microvascular endothelial cells (HBMEC)
were obtained from ScienCell Research Laboratories (Carlsbad, CA)
and cultured in fibronectin-coated tissue culture flasks and basal
medium supplemented with Endothelial Cell Growth Supplement
(ECGS) and 5% fetal bovine serum (FBS) all from ScienCell. The
mouse high endothelial venule cell line (mHEVc) (gift from Joan
Cook-Mills, Northwestern University, Chicago, IL) and mHEVc
cells stably expressing LC3-EGFP construct (mHEVc-LC3-EGFP)
or hmCD40 plus LC3-EGFP (hmCD40 mHEVc-LC3-EGFP) [15]
were cultured in DMEM plus 10% FBS (HyClone; Logan, UT). A
human RPE cell line (ARPE-19; American Type Culture Collection,
Manassas, VA), a mouse macrophage line (RAW 264.7) and mouse
microglia line (BV-2) were cultured in DMEM plus 10% FBS.
Mouse bone marrow-derived macrophages were obtained as
described and cultured in DMEM plus 30% L929-conditioned
medium, 10% FBS and 5% horse serum [68]. Parental Chinese
Hamster Ovary (CHO) cells and CHO cells expressing human
EGFR (CHO-EGFR) were cultured in MEM plus 10% FBS.
T. gondii and infection
Experiments were conducted using tachyzoites of the RH strain
of T. gondii (Type I strain), RH that express cytoplasmic YFP [69]
or cytoplasmic DsRed (RFP) [69], tachyzoites of the ME49 (type II
strain), transgenic parasites deficient in micronemal proteins
MIC1 ko, MIC3 ko, MIC1-3 ko and the complemented strains
(MIC1ko+MIC1, MIC3 ko+MIC3 and MIC1-3 ko+MIC1-3; gift
from Maryse Lebrun, Universite de Montpellier 2, France) [39], as
well as conditional MIC8 ko parasites (gift from Markus Meissner,
University of Glasgow). Parasites were maintained in human
foreskin fibroblasts following standard procedures [70]. In order to
deplete MIC8, conditional MIC8 ko parasites were cultured in
HFF in the presence of anhydrotetracycline (1 mg/ml) for 48 h. T.
gondii tachyzoites were killed by incubation in 1% paraformalde-
hyde in PBS.
A potassium buffer shift was used to synchronize T. gondii
invasion of serum-starved (0.1% FBS) mammalian cells as
described [71]. Briefly, freshly egressed tachyzoites were resus-
pended in Endo buffer and incubated with cells for 20 minutes at
37uC. The Endo buffer was replaced for a low-potassium
permissive medium to allow parasite invasion. In certain
experiments, mammalian cells were incubated with Akt inhibitor
IV (1.25 mM; EMD Millipore, Billerica, MA), PI3K inhibitor
(LY294002; 20 mM; Sigma-Aldrich; St. Louis, MO), EGFR
inhibitor (AG1478; 1 mM; EMD Millipore), a broad spectrum
ADAM inhibitor (GM6001; 10 mM; EMD Millipore) (all 1 h prior
to challenge with T. gondii), Pertussis Toxin (PTx; 100 ng/ml;
EMD Millipore; 4 h prior to challenge), leupeptin (10 mM; EMD
Millipore) and pepstatin (10 mM; EMD Millipore; both 1 h after
challenge with T. gondii), 3-methyl adenine (3MA; 10 mM; Sigma
Chemical) and rapamycin (1 mM; EMD Milipore; both 2 h after
challenge with T. gondii) or vehicle. To induce CD40 signaling,
mHEVc cells were treated with cell-free supernatants containing
either multimeric human CD154 or a non-functional CD154
mutant [72] (T147N; both obtained from Dr. Richard Kornbluth,
Univ. of California San Diego, current address Multimeric
Biotherapeutics Inc., La Jolla, CA) for 18 h at 37uC as previously
described [73] prior to challenge with parasites. Monolayers were
fixed at indicated time points and stained with Diff-Quick (Dade
Diagnostics, Aguada, Puerto Rico). The percentage of infected
cells, the numbers of tachyzoites and vacuoles per 100 cells as well
as the numbers of parasites per vacuole were determined by light
microscopy by counting at least 200 cells or 200 vacuoles per
monolayer as previously described [15].
T. gondii proteins
For expression of MIC3 and MIC4 in P. pastoris, amplified DNA
fragments were cloned into a pPICZa A vector (Invitrogen;
Carlsbad, CA). The pPICZa A vector contains the S. cervisiae a-
factor secretion signal that allows for the secretion of folded
proteins from P. pastoris. Cells were grown in BMGY media,
washed and resuspended in BMMY media for an initial OD600 of
20–40. The culture was then incubated in a 28uC incubator with
vigorous shaking. The culture was then grown for 1–5 days
depending on the optimal period of expression. Inhibition of
glycosylation during culture required the addition of 20 mg/ml of
tunicamycin. The supernatant is then passed through a HiTrap Q
HF Column (GE Healthcare; Little Chalfont, UK). The eluted
fraction was buffer exchanged into nickel-column binding buffer
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(50 mM Tric-HCl, pH 8.0, 50 mM NaCl). If needed further
protein purification was achieved by a further nickel affinity step
and gel filtration.
M2AP and MIC6 encompassing residues 87 to 197 (including
EGF2 and EGF3 motifs) were generated using a pET32 Xa/LIC
plasmid (Novagen, EMD Millipore) in the Origami (D3) Escherichia
coli strain (Stratagene) [74,75]. Expressions of the fusion protein
was induced by adding 1 mM IPTG and harvested after overnight
culture at 18uC. The cells were collected by centrifugation and
lysed by French Press. The fusion protein incorporating a
hexahistidine tag was purified by bench top chromatography
using a nickel-nitrilotriacetic acid resin (QIAGEN). The fusion
partner of protein was cleaved by factor Xa and removed by an
additional chromatography step and the factor Xa was removed
by agarose resins (Novagen). Protein samples were concentrated to
0.5 mM in 50 mM NaCl, 50 mM potassium phosphate and 5%
D2O at pH 5.8. Endotoxin concentrations were similar in MIC3
and MIC4 as well as in M2AP and MIC6.
Transfection
Cells were transiently transfected with a plasmid that encodes
Akt-PH-GFP [76], human PI3K p110a siRNA [77], human Akt
siRNA [78], mouse Beclin1 siRNA [79], mouse Atg7 siRNA [79],
human MyD88 siRNA [80], human EGFR siRNA [81] or control
siRNA (Dharmacon) using Lipofectamine 2000 (Invitrogen) or an
Amaxa nucleofector as described [13,15]. siRNA against mouse
EGFR was synthesized using siRNA construction kit (Ambion)
[82] following manufacturer’s recommendation and used for
mouse EGFR knock-down after transfection using Lipofectamine
2000.
Fluorescent microscopy
To assess for LC3 accumulation around the parasite, mHEVc-
LC3-EGFP cells were cultured with or without Akt inhibitor IV or
transfected with either control siRNA or EGFR siRNA or treated
with or without EGF (50 ng/ml; PeproTech). Monolayers were
challenged with RH T. gondii that express cytoplasmic RFP (T.
gondii-RFP). Five hours post-challenge, monolayers were fixed with
4% paraformaldehyde, slides were mounted using Fluoromount G
and assessed for LC3-EGFP accumulation around T. gondii as
described [13,15]. In certain experiments, hmCD40 mHEVc-
LC3-EGFP cells treated with or without CD154 were infected
with WT, MIC1 ko, MIC1 ko+MIC1, MIC3 ko, MIC3
ko+MIC3, MIC1-3 ko or MIC1-3 ko+MIC1-3 tachyzoites.
Monolayers were fixed with 4% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and incubated with rabbit anti-T. gondii
Ab (BioGenex; San Ramon, CA) for 30 minutes. Monolayers were
then washed with PBS and incubated for 1 h at room temperature
with goat anti-rabbit Alexa 568-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories Inc., West Grove, PA).
HBMEC transfected with a plasmid encoding PH-Akt-GFP were
cultured with or without LY294002 followed by challenge with T.
gondii-RFP. Distribution of PH-Akt-GFP was examined 5 min.
post-challenge. In certain experiments, endothelial cells were
treated with either Akt inhibitor IV or AG1478 and challenged
with T. gondii-YFP were fixed with 4% paraformaldehyde at 8 h
post-infection, permeabilized with ice-cold methanol. Monolayers
were incubated overnight at 4uC with either mouse anti-human
LAMP-1 or rat anti-mouse LAMP-1 (all from Developmental
Studies Hybridoma Bank; Iowa City, IA). Monolayers were
washed with PBS plus 1% BSA, then incubated for 1 h at room
temperature with Alexa 568-conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories Inc.). Specificity of
staining was determined by incubating monolayers with secondary
antibody alone. Slides were analyzed using a Leica DMI 6000 B
automated microscope equipped for epifluorescence microscopy.
Experimental groups had triplicate samples and at least 100 cells
per sample were counted.
Electron microscopy
Endothelial cells were seeded onto a sterilized Aclar Embedding
Film (Electron Microscopy Sciences, PA) and incubated with or
without T. gondii tachyzoites in the presence of Akt inhibitor IV or
vehicle. At 5 h post-challenge, the Aclar sheets with their attached
cells were fixed as described [83]. After a soak in acidified uranyl
acetate, the specimen was dehydrated in ethanol, passed through
propylene oxide, and embedded in Poly/Bed (Polysciences, PA).
Sections were cut in a horizontal plane parallel to that of the Aclar
film to provide panoramic views of the endothelial cells. Thin
sections were stained with acidified uranyl acetate in 50%
methanol followed by triple lead stain of Sato. These sections
were examined in a JEOL 1200 EX electron microscope (Tokyo,
Japan).
Immunoblot
Cells were lysed in buffer supplemented with protease and
phosphatase inhibitors (Cell Signaling). Equal amounts of protein
were subjected to either 7.5% or 10% SDS-PAGE (Bio-Rad) and
transferred to PVDF membranes. Membranes were probed with
either antibody to total Akt (Cell Signaling), phospho-Ser473 Akt
(Cell Signaling), total EGFR (Santa Cruz Biotechnology),
phospho-tyrosine 1068 EGFR (Invitrogen), phospho-tyrosine
1148 EGFR (Cell Signaling), Atg7 (Cell Signaling), Beclin 1 (BD
Biosciences), PI3K p110a (Cell Signaling) or MyD88 (Cell
Signaling) followed by incubation with secondary antibody
conjugated to horseradish peroxidase (Santa Cruz Biotechnology).
Bands were visualized by using enhanced chemiluminescence kit
(Pierce Bioscience). Intensities of phospho-Akt and phospho-
EGFR were calculated using ImageJ (NIH) and normalized
against total Akt and total EGFR respectively.
Statistics
Results from pooled experiments were analyzed for statistical
significance using 2-tailed Student’s t test and ANOVA (InStat
version 3.0, GraphPad; La Jolla, CA). Differences were considered
statistically significant when P was,0.05.
Supporting Information
Figure S1 Effects of Akt blockade on the numbers of T.
gondii-containing vacuoles and the numbers of parasites
per vacuole. A, HBMEC, mHEVc and human RPE cells were
incubated with or without Akt inhibitor IV (1.25 mM) for 1 h prior
to challenge with T. gondii. In addition, HBMEC were transfected
with control siRNA or Akt siRNA. Cells were then challenged
with T. gondii 48 h after transfection. Monolayers were examined
by light microscopy 24 h post-challenge to determine the numbers
of parasite containing vacuoles. B, HBMEC were transfected with
control siRNA or Akt siRNA and were then challenged with T.
gondii. Monolayers were examined by light microscopy 24 h post-
challenge to determine the numbers of parasites per vacuole.
Results are shown as the mean 6 SEM and are representative of
at least 3 independent experiments.
(TIF)
Figure S2 Effects of MIC8 depletion on Akt activation.
Conditional MIC8 ko parasites were cultured in HFF with or
without ATc (1 mg/ml) for 48 h. Tachyzoites were harvested and
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incubated with HBMEC for the indicated time points. Cell lysates
were used to probe for total Akt and phospho-Ser473 Akt by
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